Approved for ZAVZPRET is indicated for the acute treatment of migraine with or without aura in adults. Limitations of Use ZAVZPRET is not indicated for the preventive treatment of migraine.. Zavegepant is a calcitonin gene-related peptide (CGRP) receptor antagonist. Side effects, costs, interactions, manufacturer, and generic alternatives sourced from FDA labels, openFDA FAERS, and CMS NADAC…
Loading full data from Know Your Drugs Institute…